trial

Sustained Attention Abilities in Schizophrenia

NCTId NCT02388607
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 80 (estimated)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2023-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
80 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2015-03
Primary completion
2023-03
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
measurements

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Investigators

2
Giersch Anne, MDPrincipal Investigator
Bonnefond Anne, PHDStudy Chair

Sites

1 total
Strasbourg, France

Facts & assertions

4 sourced
Enrollment
80
Phase
NA
Primary Completion Date
2023-03
Status
UNKNOWN
relationships
The graph out of here
drug
measurements
drug
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Schizophrenic Psychoses
indication
investigator
Giersch Anne, MD
person
Bonnefond Anne, PHD
person